Engineering exosomes: a new direction for anticancer treatment
Benshuai You1, Wenrong Xu1, Bin Zhang2
1Key Laboratory of Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University Zhenjiang, Jiangsu, P. R. China.
Abstract:
Currently, lacks of specificity and effectiveness remain the main drawbacks of clinical cancer treatment. Despite therapeutic advances in recent decades, clinical outcomes remain poor. Exosomes are nanosized particles with great potential for enhancing anticancer responses and targeted drug delivery. Exosomes modified through genetic or nongenetic methods can augment the cytotoxicity and targeting ability of therapeutic agents, thus improving their efficacy in killing cancer cells. In this review, we summarize recent research on engineering exosomes-based cancer therapy and discuss exosomes derived from tumors, mesenchymal stem cells, dendritic cells, HEK293T cells, macrophages, milk, and other donor cells. The antitumor effects of engineered-exosomes are highlighted and the potential adverse effects are considered. A comprehensive understanding of exosomes modification may provide a novel strategy for cancer therapy.
Insights
Engineered exosomes show promise for improving cancer treatment by enhancing drug delivery and cancer cell killing. This review explores modified exosomes from various sources for novel cancer therapy strategies.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Clinical cancer treatment faces challenges with specificity and effectiveness, leading to poor outcomes despite advances.
- Exosomes, as natural nanosized vesicles, offer potential for improved anticancer responses and targeted drug delivery.
- Current therapeutic strategies require enhancement for better efficacy in cancer patient care.
Purpose of the Study:
- To review recent advancements in engineering exosomes for cancer therapy.
- To discuss the potential of modified exosomes in augmenting anticancer efficacy and drug delivery.
- To explore exosomes derived from diverse cell sources for therapeutic applications.
Main Methods:
- Summarizing current research on engineered exosomes for cancer treatment.
- Analyzing exosomes derived from various sources including tumors, stem cells, and HEK293T cells.
- Evaluating genetic and nongenetic modification strategies for exosome-based therapies.
Main Results:
- Engineered exosomes demonstrate augmented cytotoxicity and targeting ability against cancer cells.
- Exosomes from different sources exhibit varying potential for therapeutic modifications.
- Modification strategies can enhance the efficacy of therapeutic agents delivered via exosomes.
Conclusions:
- Engineering exosomes presents a promising novel strategy for enhancing cancer therapy.
- Further understanding of exosome modification can lead to improved clinical outcomes.
- Exosome-based therapies offer a potential alternative to overcome current treatment limitations.
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
What is Genetic Engineering?
Directing Effect of Substituents: meta-Directing Groups
Heat Engines
Whenever we consider heat engines (and associated devices such as refrigerators and heat pumps), we do not use the standard sign convention for heat and work. For convenience, we assume that the symbols Qh, Qc, and W represent only the amounts of heat transferred...
Directing Effect of Substituents: ortho–para-Directing Groups
Directional Terms


